Gelonghui October 27?300511.SZ released its report for the third quarter of 2023, with operating income of 569 million yuan during the reporting period, down 15.86% from the same period last year; net profit belonging to shareholders of listed companies was-169 million yuan; net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was-172 million yuan; basic earnings per share was-0.34 yuan.
雪榕生物(300511.SZ)：第三季度净亏损1.69亿元
Xuerong Biotech (300511.SZ): Net loss of 169 million yuan in the third quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.